Douglas F. Kling
2015
In 2015, Douglas F. Kling earned a total compensation of $344.4K as Senior Vice President, Clinical Development & Project Management at Matinas BioPharma Holdings.
Compensation breakdown
| Option Awards | $145,602 |
|---|---|
| Salary | $198,840 |
| Total | $344,442 |
Kling received $198.8K in salary, accounting for 58% of the total pay in 2015.
Kling also received $145.6K in option awards.
Rankings
In 2015, Douglas F. Kling's compensation ranked 11,987th out of 13,638 executives tracked by ExecPay. In other words, Kling earned more than 12.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,987 out of 13,638 | 12th |
Division Manufacturing | 4,601 out of 5,187 | 11th |
Major group Chemicals And Allied Products | 1,688 out of 1,857 | 9th |
Industry group Drugs | 1,398 out of 1,531 | 9th |
Industry Pharmaceutical Preparations | 1,080 out of 1,179 | 8th |
Source: SEC filing on September 14, 2017.
Kling's colleagues
We found three more compensation records of executives who worked with Douglas F. Kling at Matinas BioPharma Holdings in 2015.